Cardiotrophin 1

Today, Cardiotrophin 1 is a topic of great relevance and interest to a wide variety of people. Whether due to its impact on society, its influence on popular culture or its importance in the professional field, Cardiotrophin 1 has become a recurring topic of conversation around the world. With its variety of facets and its ability to generate debate, Cardiotrophin 1 remains an ever-evolving topic that continues to capture the audience's attention and curiosity. In this article, we will explore in detail different aspects of Cardiotrophin 1, its impact and its relevance today.

cardiotrophin 1
Identifiers
SymbolCTF1, CT1, CT-1
NCBI gene1489
HGNC2499
OMIM600435
RefSeqNM_001330
UniProtQ16619
Other data
LocusChr. 16 p11.2-16p11.1
Search for
StructuresSwiss-model
DomainsInterPro

Cardiotrophin-1 (CT-1) is a cytokine. It is a cardiac hypertrophic factor of 21.5 kDa and a protein member of the IL-6 cytokine family.

Pathology

CT-1 is associated with the pathophysiology of heart diseases, including hypertension, myocardial infarction, valvular heart disease, and congestive heart failure.

Mode of action

The protein exerts its cellular effects by interacting with the glycoprotein 130 (gp130)/leukemia inhibitory factor receptor beta (LIFR) heterodimer. In addition, CT-1 activates phosphatidylinositol 3-kinase (PI-3 kinase) in cardiac myocytes and enhances transcription factor NF-κB DNA -binding activities.

CT-1 is highly expressed in the heart, skeletal muscle, prostate and ovary and to lower levels in lung, kidney, pancreas, thymus, testis and small intestine. [1]


References

  1. ^ "Recombinant human Cardiotrophin 1 protein (ab9838)". www.abcam.com. Retrieved 2017-08-09.